COMPOSITION CONTAINING AN INHIBITOR OF SIGNAL TRANSDUCTION OF HETEROTRIMERIC G-PROTEINS IN COMBINATION WITH ANOTHER ANTI-CANCER MEDIUM TO THERAPEUTIC USE IN CANCER TREATMENT

摘要

A novel product comprises heterotrimeric G protein signal transduction inhibitor(s) (I) and other anticancer agent(s) (II) selected from prenyl transferase inhibitors, taxol (or analogs), gemcitabin and camptothecin (or analogs), for simultaneous, separate or successive therapeutic use in the treatment of cancer.